[HTML][HTML] Osteoporosis: current concepts

I Akkawi, H Zmerly - Joints, 2018 - thieme-connect.com
Osteoporosis is a worldwide disease characterized by reduction of bone mass and alteration
of bone architecture resulting in increased bone fragility and increased fracture risk. Causes …

[HTML][HTML] Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment

L Hu, C Yin, F Zhao, A Ali, J Ma, A Qian - International Journal of …, 2018 - mdpi.com
Osteoporosis is a progressive skeletal disease characterized by decreased bone mass and
degraded bone microstructure, which leads to increased bone fragility and risks of bone …

Sarcoidosis: a review for the internist

E Bargagli, A Prasse - Internal and Emergency Medicine, 2018 - Springer
Sarcoidosis is a systemic granulomatous lung disease of unknown origin affecting people of
any age, mainly young adults. The disease is extremely heterogeneous with an …

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis

S Minisola, C Cipriani, GD Grotta… - Therapeutic …, 2019 - journals.sagepub.com
Following the completion of the Fracture Prevention Trial, teriparatide was approved by the
United States Food and Drug Administration and the European Medicine Agency as the first …

[HTML][HTML] Sclerostin and vascular pathophysiology

A Catalano, F Bellone, N Morabito, F Corica - International Journal of …, 2020 - mdpi.com
There is cumulating evidence for a contribution of Wnt signaling pathways in multiple
processes involved in atherosclerosis and vascular aging. Wnt signaling plays a role in …

[HTML][HTML] Gender Disparities in Osteoporosis Knowledge, Health Beliefs and Preventive Behaviors in Najran City, Saudi Arabia

HA Ibrahim, MH Nahari, MA Al-Khadher, NI Ismail… - Nutrients, 2023 - mdpi.com
Osteoporosis is a chronic bone disease affecting both men and women, but it is more
prevalent in women. Promoting a healthy lifestyle among adults, particularly women, is …

[HTML][HTML] Exploring the bone sparing effects of postbiotics in the post-menopausal rat model

N Montazeri-Najafabady, Y Ghasemi… - … Medicine and Therapies, 2021 - Springer
Background Post-menopausal osteoporosis is a concern of health organizations, and
current treatments do not seem enough. Postbiotics as bioactive compounds produced by …

Understanding and managing secondary osteoporosis

L Colangelo, F Biamonte, J Pepe… - Expert Review of …, 2019 - Taylor & Francis
Introduction: The term secondary osteoporosis (SO) identifies a reduction of bone mass
related to a well-established disease or pharmacological agent. The identification of the …

Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia

L Colangelo, J Pepe, L Nieddu, C Sonato… - Osteoporosis …, 2020 - Springer
This paper reports our personal experience filling the gap regarding changes of bone
mineral density after surgical treatment in patient suffering from tumor-induced …

Novel reduced graphene oxide/zinc silicate/calcium silicate electroconductive biocomposite for stimulating osteoporotic bone regeneration

K Xiong, T Wu, Q Fan, L Chen… - ACS applied materials & …, 2017 - ACS Publications
In the absence of external assistance, autogenous healing of bone fracture is difficult due to
impaired regeneration ability under osteoporosis pathological conditions. In this study, a …